Navigation Links
Conference report highlights new research into drug delivery to treat eye disease
Date:11/17/2008

itive polymers to help deliver one of the latest drugs, silencing RNA (siRNA).

Another group of presenters discussed the use of nanoparticles, microbeads and microneedles. Mansoor M. Amiji, PhD, said that nanoparticles can help overcome barriers to drug delivery from the organ level to the subcellular level. Another research laboratory was investigating the effectiveness of hollow and solid microneedles that penetrate only hundreds of micrometers into the cornea or sclera to deliver drugs.

A safer alternative to direct intravitreous injections might be transscleral delivery into the vitreous using subconjunctival injections, said Michael Robinson, MD, adding that researchers needed a clear understanding of the dynamic barriers for the technique to work in treating retinal diseases. Another researcher in this area, Dayle H. Geroski, PhD, suggested that the relatively high permeability of the sclera offers great potential for transscleral drug delivery, especially for administration to the posterior part of the eye.

Other research focused on photodynamic therapy, which uses a photosensitizer agent that localizes more or less selectively to the target tissue and is activated by light, triggering chemical reactions that injure the target tissue.


'/>"/>

Contact: Jo Olson
jolson@arvo.org
240-221-2923
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...,s Bioprocessing Technology Institute (BTI) have m...ptosis inhibitory molecule" (FAIM), protects both ...ed cell death. , Their research is published in...on . , The scientists, Jianxin Huo, Ph.D., and S...s may possibly be manipulated for clinical applica...
(Date:7/2/2009)...wswire-USNewswire/ -- Pro-life forces won an impor...ruled to uphold a state law regulating that aborti...administering RU-486 (also known as the "abortion ...ng the drug. , , The ruling came in Rogers v....thood to a 2004 law requiring that those administe...
(Date:7/2/2009)...n help reduce threat, expert says , , T...jor threat to certain species of wildlife, which n...earchers say. , "Cancer is one of the leading h...n 10 percent of human deaths. But we now understan...es," lead author Denise McAloose, chief pathologis...
(Date:7/2/2009)... biological issues need to be addressed in order t...tion of cancer, according to a commentary publishe...ncer Institute . , The biomarker pipeline to dev...the identification of promising biomarkers to dete...aluation of biomarkers for cancer screening. , ...
Breaking Medicine News(10 mins):Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Cancer Endangers Some Wildlife Species 2
...nister K.K.S.S.R. Ramachandran commissioned a spec...related disorders at the Government General Hospit...dvanced therapeutic options to diseases like jaund..., will also focus on preventive measures - said S....
...hicles in the metros today have caused troubles to...carry trauma patients in time to the hospitals. ‘...ity's traffic-heavy roads is not an easy one’ says...s ‘despite of being equipped with sirens, ambulanc...
...ied out by the Indian Council of Medical Research ...tional male in mind is too big for the Indian man.... that about 50% of the men had penises shorter by...ll or slip off leading to a failure rate of 20 % ....
... tune of US$476 million have been donated for the ...e Mali conference on Friday. Already about US$600 ...n collected after the January conference in Beijin... to combat the deadly H5N1 bird flu strain, as it ...
Other Medicine News:
(Date:6/29/2009)...eks to Assess RSV Burden in Outpatient Setting Dur...Pediatric Research , , GAITHERSBURG, Md., Jun...e its commitment to pediatric research with today,...ive study designed to assess the burden of respira...2-to-35 weeks gestational age (GA) in outpatient s...
(Date:6/28/2009)...ne 29 Sangamo BioScience...ey research milestone has been achieved in its Res...a wholly-owned member of the Roche Group, for the ...s for pharmaceutical protein production purposes u... protein nuclease (ZFN) technology. Genentech scie...
(Date:6/26/2009)...ase, "Agendia,s Breast Cancer Recurrence Test Mamm...t Consensus Recommendations" issued,on 23 Jun 200...ase be advised,that the subheadline was missing f...Newswire. Complete, corrected release follows: ,...st Cancer Recurrence Test MammaPrint Included in,...
(Date:6/25/2009)...e 25 "Congratulations President Ob...mpanies to cut prescription costs for the elderly,...any, Inc. "We thought you should know that you hav...ame for psoriasis sufferers of all ages." , , M...., and the submission of their findings from a rec...
Breaking Medicine Technology:MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 2Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech 3/C O R R E C T I O N -- Agendia B.V./ 2/C O R R E C T I O N -- Agendia B.V./ 3Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform 2Zebra Technologies Introduces New Soft Infant Wristbands for Improved Safety and Comfort 38396 1Zebra Technologies Introduces New Soft Infant Wristbands for Improved Safety and Comfort 38396 2Zebra Technologies Introduces New Soft Infant Wristbands for Improved Safety and Comfort 38396 3Texas Cardiac Arrhythmia Institute at St Davids Medical Center First in Nation to Use NaviStar 28R 29 RMT ThermoCool 28R 29 Catheter Since Technology 38392 1Texas Cardiac Arrhythmia Institute at St Davids Medical Center First in Nation to Use NaviStar 28R 29 RMT ThermoCool 28R 29 Catheter Since Technology 38392 2Texas Cardiac Arrhythmia Institute at St Davids Medical Center First in Nation to Use NaviStar 28R 29 RMT ThermoCool 28R 29 Catheter Since Technology 38392 3Supportive co parenting may reduce some child behavior problems 38388 1Supportive co parenting may reduce some child behavior problems 38388 2Supportive co parenting may reduce some child behavior problems 38388 3Birds in Flint Hills of Kansas Oklahoma face population decline despite large habitat 7362 1Birds in Flint Hills of Kansas Oklahoma face population decline despite large habitat 7362 2Birds in Flint Hills of Kansas Oklahoma face population decline despite large habitat 7362 3
... ApoCell, Inc. presented the,results of a study co...o and ApoCell at the 2007 annual meeting of the Am... Chicago in early June.,The study showed that ApoC...hnology provides reliable predictive data of clini...ating aggressive head,and neck cancer patients wit...
...in sedation during the,early post-operative period...t reduction in nausea in the female,patient popula...e 2007 - CeNeS Pharmaceuticals plc (AIM:,CEN), the...ces,additional data from post-hoc analysis of the ...-glucuronide) in over 500 patients,with post-opera...
Other Medicine Technology:ApoCell's Cancer Predictive Index Helps Oncologists Select the Most,Effective Targeted Drug Therapy 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7
Maximize blood flow while minimizing the pain of a finger stick with the safety-engineered BD Microtainer Genie Lancet. The BD Microtainer Genie Lancet offers a full range of blades and needles for c
The DiaSTAT™ is an automated liquid chromatography system designed for the rapid and automated analysis of hemoglobin A1C. Ideal for low and ,medium volume testing environments.
The HEMOCHRON Jr. Signature+ Microcoagulation System offers point-of-care monitoring with numerous features to meet the needs of each individual department, as well as the needs of regulatory complia
Inquire
Medicine Products: